The MS4A6A gene helps make a protein on the surface of certain immune cells, including microglia, the brain’s support and cleanup cells. This gene plays an important role in how cells send and receive signals, so if it works differently, immune activity in the brain may shift. Some differences in the MS4A6A gene have been linked to a changed risk of Alzheimer’s disease, but they do not diagnose it on their own. Most variants in this gene have little effect on health.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that do the work. Other genes mainly help determine when certain processes happen, where they occur, and how strongly they run. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To explore this subject in greater depth, you can find more in the LearnHub.
Overview
MS4A6AGene function
What if the gene works
The MS4A6A gene helps support signaling in immune cells, especially microglia in the brain. This activity may shape inflammatory responses and everyday brain tissue upkeep.
Risk
What if the gene does not work
Changes in the MS4A6A gene may alter how much MS4A6A protein is made or how it works at the cell surface. Milder and more severe variants can affect immune cell signaling and protein movement by different amounts.
Treatment
What does that mean for your treatment
No treatment or management approach specific to pathogenic or loss-of-function variants in the MS4A6A gene is currently established in clinical guidelines. The MS4A6A gene is being studied as an Alzheimer disease risk-related biomarker and possible immune pathway target, but this has not changed routine drug choices.
Gene function
What if the gene works
In immune cells, the MS4A6A gene helps make a small protein that sits in the cell membrane. A key part of MS4A6A gene function is helping certain immune cells manage signals at their surface. It is most active in myeloid immune cells, including monocytes, macrophages, and microglia in the brain.
The MS4A6A protein sits in the cell membrane and passes through it four times. This position lets it take part in cell surface signaling and interact with nearby proteins.
In myeloid immune cells, such as monocytes and macrophages, MS4A6A supports how outside messages are received and passed along. This helps routine immune cell communication stay coordinated.
In the brain, MS4A6A is active in microglia, the immune cells that monitor the local environment. Normal activity supports brain immune cell function and everyday signal sensing.
What is a variant?
A genetic variant is a minor alteration in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MS4A6A gene often change how much RNA or protein a cell makes, rather than creating a completely altered protein. Most studied changes are common regulatory variants with subtle effects, while rarer coding variants may more strongly reduce protein stability, membrane placement, or interactions with nearby cell proteins. This means the functional impact can range from mild shifts in gene activity to more marked disruption of protein behavior in the cell.
How variants are linked to conditions
Variants in the MS4A6A gene have been linked mainly to late-onset Alzheimer disease in large population studies. In research on the MS4A6A gene and Alzheimer disease risk, these changes appear to slightly raise or lower the chance of developing the condition rather than cause it directly. These findings help describe overall risk patterns, but they do not confirm whether one person will develop dementia.
A variant is not necessarily a diagnosis
Genetic variants are a routine feature of human biology and are widespread in the general population. Most do not have a direct effect on health and simply represent natural variation among people. For many genes, carrying a variant associated with a condition suggests a possible link rather than a firm diagnosis, especially when several genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the MS4A6A gene itself. Some changes near MS4A6A have been linked with Alzheimer disease risk, but this effect is only one small part of overall risk, which is also shaped by age, other genes, and general health.
Inheritance of MS4A6A variants
There is not yet a broadly confirmed inheritance pattern tied to a specific MS4A6A-related condition, so inheritance of the MS4A6A gene variants is still understood mainly as part of general genetic risk rather than a single dominant or recessive syndrome. The MS4A6A gene is located on chromosome 11, which is an autosome, so you inherit one copy from each parent. In practice, a variant in the MS4A6A gene may be passed down through either side of the family.
What does my MS4A6A result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific condition for MS4A6A. Some changes in this gene have been linked with differences in risk, rather than a clear inherited condition, so what a result means for family members depends on the full genetic and health picture.
Genetic information
Genetic testing
How you find out about variants
MS4A6A genetic testing for Alzheimer’s disease risk is usually done through a saliva or blood sample, with a lab checking the MS4A6A gene for common variants. Results can help estimate inherited susceptibility, but they do not diagnose Alzheimer’s or show whether symptoms will appear.
When should I consider getting a genetic test?
There is not a broadly established clinical reason to test the MS4A6A gene on its own. Changes near or in this gene have been linked to small differences in Alzheimer’s disease risk, but they do not diagnose the condition, so testing decisions are best made with a doctor or genetic counselor based on your personal and family history.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals depends on the condition and the specific type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, seems less effective for another, or causes more side effects in someone else. These differences are common and often relate to how the body breaks down, moves, or responds to a drug, which can influence both benefit and sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences can shape a person’s response to medicines. By looking at how genes relate to specific drugs, it helps explain why the same treatment may not work in the same way for everyone. With many medications, genes influence either how powerfully a drug works or how the body processes it. Understanding this can support treatment choices that are both more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the MS4A6A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or how people respond to them. General health concerns, new symptoms, or questions about side effects and treatment changes are best discussed with your doctor or pharmacist.